[Shinji Fukuda] Development of fundamental technology for preventive and therapeutic medicine through intestinal metabolites-targeted approach

PRESTO Researcher

Shinji Fukuda

Shinji Fukuda

Graduate School of Media and Governance, Keio University
Project Associate Professor

Outline

Gut microbiota-derived metabolites have been known as a key player to modulate host physiological homeostasis; however, there is no appropriate technique to control intestinal metabolites produced by gut microbiota. Thus, taking advantage of cutting-edge technologies such as microfluidics and metabologenomics, we try to develop a novel preventive and therapeutic approach through food-mediated modulation of intestinal metabolites produced by gut microbiota as a self-medication strategy. The goal of this study is to develop a fundamental technology to control gut microbiota-derived metabolites at will.

Quick Access

Quick Access

 News

arrow On-going

arrow Completed

Program

  • CREST
  • PRESTO
  • ACT-I
  • ERATO
  • ACT-C
  • ACCEL
  • ALCA
  • RISTEX
Finish programs
  • Pamphlet
  • ProjectDB
  • GlobalActivity
  • Diversity-EN
  • OS_Policy-EN
  • Question-E